Nov 22, 2024; Philadelphia, Pennsylvania, USA; Philadelphia 76ers guard Jared McCain (20) smiles as he looks on during a break in the second quarter against the Brooklyn Nets at Wells Fargo Center.

Click to share on Facebook (Opens in new window) Facebook Click to share on X (Opens in new window) X Jewel is feeling like a “Stronger Woman” — and her fitness transformation proves it. The singer, ...

Pfizer PFE0.38%increase; green up pointing triangle has agreed to pay up to $7.3 billion for weight-loss drug developer Metsera MTSR-0.29%decrease; red down pointing triangle in a deal that gets the ...

From fibres to antioxidants in green tea, neuroscientist Robert Love outlines 3 natural supplements that can support weight loss and how they work. The journey to weight loss can often feel ...

Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...

Experts suggest that walking after strength training can significantly boost fat loss. Weight lifting depletes glycogen stores, prompting the body to burn fat during subsequent low-intensity walking.

How much weight can a hawk carry? The answer varies depending on the type of hawk. Though North America boasts approximately 18 distinct hawk species, we focus on the magnificent red-tailed hawk. As ...

By Mariam Sunny and Michael Erman (Reuters) - Pfizer said on Monday it would acquire drug developer Metsera in a deal valued at up to $7.3 billion, including future payments, as it seeks to gain a ...

Courtesy of the Drinks Update, restaurateurs can now diversify their menu in Restaurant Tycoon 3. A range of stations and machines, such as a Coffee Machine and a Milkshake Bar, can be purchased from ...

(Reuters) -Pfizer (PFE) said on Monday it would acquire drug developer Metsera (MTSR) in a deal valued at up to $7.3 billion, including future payments, as it seeks to gain a foothold in the ...

Pfizer said it would pay as much as $7.3 billion for Metsera as it looks to profit from soaring demand for weight-loss medicines. Metsera investors will get $47.50 per share for each share they own, ...

Metsera brings its portfolio of experimental obesity drugs, with MET-097i, a GLP-1 injectable, and MET-233i, which mimics the pancreatic hormone amylin, being the key among them. MET-233i is being ...